• No results found

University of Groningen Towards novel biomarkers and rational nutritional interventions in Inflammatory Bowel Disease von Martels, Julius Zweder Hubertus

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Towards novel biomarkers and rational nutritional interventions in Inflammatory Bowel Disease von Martels, Julius Zweder Hubertus"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Towards novel biomarkers and rational nutritional interventions in Inflammatory Bowel

Disease

von Martels, Julius Zweder Hubertus

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

von Martels, J. Z. H. (2019). Towards novel biomarkers and rational nutritional interventions in Inflammatory Bowel Disease. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Towards novel biomarkers and

rational nutritional interventions in

Inflammatory Bowel Disease

(3)

The research position of drs. J.Z.H. von Martels was financially supported by the Top Institute Food and Nutrition (TiFN) in Wageningen and the Center for Development and Innovation (CDI) of the University Medical Center Groningen (UMCG).

For the financial support in the printing costs of this thesis I gratefully acknowledge the following institutions:

- Graduate School of Medical Sciences of the UMCG - University of Groningen

- DSM Nutritional products (see below for the logo)

ISBN (printed version): 978-94-6323-587-7 ISBN (electronic version): 978-94-6323-638-6

Cover design: Ilse Modder (www.ilsemodder.nl) Lay-out: Ilse Modder (www.ilsemodder.nl) Printed by: Gildeprint - Enschede

© 2019 Julius Z.H. von Martels

All rights reserved. No part of this thesis may be reprinted, reproduced, or utilized in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording of any information storage or retrieval system, without prior written permission of the author.

(4)

Towards novel biomarkers and

rational nutritional interventions in

Inflammatory Bowel Disease

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. E. Sterken

en volgens besluit van het College voor Promoties. De openbare verdediging zal plaatsvinden op

woensdag 5 juni 2019 om 14.30 uur

door

Julius Zweder Hubertus von Martels

geboren op 21 oktober 1987 te Groningen

(5)

Promotores Prof. dr. G. Dijkstra Prof. dr. P. de Vos Prof. dr. K.N. Faber Copromotor Dr. H.J.M. Harmsen Beoordelingscommissie Prof. dr. J.H. Kleibeuker Prof. dr. G. Bouma Prof. dr. C.Y. Ponsioen

(6)

Paranimfen

A.R. Bourgonje S.F.E. Paas

(7)
(8)

TABLE OF CONTENTS

Chapter 1 General introduction and outline of this thesis

Chapter 2 The role of gut microbiota in health and disease: In vitro modeling of host-microbe interactions at the aerobe-anaerobe interphase of the human gut

Chapter 3 A simple coculture system shows mutualism between anaerobic faecalibacteria and epithelial Caco-2 cells

Chapter 4 Increased fecal calprotectin levels in Crohn’s disease correlate with elevated serum Th1- and Th17-associated cytokines Chapter 5 A combined set of four serum inflammatory biomarkers reliably

predicts endoscopic disease activity in Inflammatory Bowel Disease

Chapter 6 Crohn’s disease in clinical remission is marked by systemic oxidative stress

Chapter 7 Assessing intestinal permeability in Crohn’s disease patients using orally administered 52Cr-EDTA

Chapter 8 Riboflavin suppresses inflammation and attenuates Crohn’s disease symptoms (RISE-UP Study)

Chapter 9 Summary, discussion and future perspectives Addendum Nederlandse samenvatting

List of Publications Author Affiliations Curriculum Vitae Dankwoord 11 23 49 69 87 123 145 167 209 222 227 229 230 231

(9)

Referenties

GERELATEERDE DOCUMENTEN

Within this CD cohort, we study putative associations between plasma free thiols and established disease parameters, especially markers of inflammatory disease activity... Barrier

Examples of systems that are used to study the human gut microbiota in isolation are the TNO dynamic in vitro model of the human large intestine (TIM-2), the Simulator of the

Thus, the HoxBan coculture system presented here demon- strates for the first time mutualism between oxygen-requiring intestinal epithelial cells (Caco-2) and an

In the present study, serum IFN-γ levels were significantly elevated in CD patients with increased fecal calprotectin levels, as compared to patients with remissive disease..

Using the composite IBD endoscopy score, patients with high endoscopic disease ac- tivity (either moderate (2) or severe (3)) demonstrated significantly elevated serum con-

In this study, we demonstrate that albumin-adjusted plasma free thiol concentrations are significantly decreased in Crohn’s disease (CD) in clinical remission as compared to

Hence, in Chapter 7, the study design of a randomized placebo-controlled trial (RCT) will be described. This multicenter RCT is set-up to study the effects of 1) dietary

Good evidence on types of dietary fibers is lacking, hence, specific advice cannot be given to IBD patients (this thesis). If the Groningen Anti-Inflammatory Diet (GrAID)